We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

ELEKTA

Elekta develops tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well a... read more Featured Products: More products

Download Mobile App




New European Partnership Designed to Increase Radiation Therapy Awareness

By MedImaging International staff writers
Posted on 15 Feb 2017
Print article
Image: The Infinity radiation therapy system (Photo courtesy of Elekta).
Image: The Infinity radiation therapy system (Photo courtesy of Elekta).
A new partnership has been agreed between a European cancer foundation and a human care company to optimize patient access to state-of-the-art radiation therapy in Europe.

The partnership will address patient access to radiation therapy, as part of the comprehensive cancer care cycle, in Eastern and South-Eastern Europe by initiating programs with industry and academic partners, and patient advocacy groups.

The European Society for Radiotherapy & Oncology (ESTRO) Cancer Foundation and Elekta agreed the new partnership. The ECF aims to provide access to state-of-the-art radiation therapy as part of a multidisciplinary approach for personalized cancer care. Elekta is a human care company that develops tools and treatment planning systems for radiation therapy, brachytherapy, radiosurgery, brain disorders, and software intended to enhance the cancer care workflow.

Senior VP Elekta, Region Europe, Francois Pointurier, said, "Elekta has had a strong relationship with ESTRO for many years. With the other partners working with ECF, we are stronger in our mission to ensure that individuals in every European country that could benefit from radiation therapy receive the treatment they need. With hope and hard work this partnership will radically improve the visibility of radiation therapy within Europe and parts of Asia. A 2013 Lancet study showed that dated cobalt 60 technology is still in significant use in parts of east and southeast Europe. In addition, in 28 of the 33 European countries studied, there were less than four radiotherapy machines per radiation therapy center. Especially in east and southeast Europe, countries need to expand and modernize their radiation therapy equipment."

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Laptop Ultrasound Scanner
PL-3018
New
Color Doppler Ultrasound System
DRE Crystal 4PX
New
Ultrasound Table
Powered Ultrasound Table-Flat Top

Print article

Channels

Nuclear Medicine

view channel
Image: The AI system uses scintigraphy imaging for early diagnosis of cardiac amyloidosis (Photo courtesy of 123RF)

AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging

Cardiac amyloidosis, a condition characterized by the buildup of abnormal protein deposits (amyloids) in the heart muscle, severely affects heart function and can lead to heart failure or death without... Read more

General/Advanced Imaging

view channel
Image: The Cinematic Reality app enables interaction with realistic renderings of human anatomy (Photo courtesy of Siemens)

AR Application Turns Medical Scans Into Holograms for Assistance in Surgical Planning

Siemens Healthineers (Erlangen, Germany) has launched an app designed for Apple Vision Pro that allows users including surgeons, medical students, or patients to view immersive, interactive holograms of... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: Samsung Medison CEO Mr. Yongkwan Kim and Bracco Imaging CEO Dr. Fulvio Renoldi Bracco endorsed a MoU agreement (Photo courtesy of Bracco Group)

Samsung and Bracco Enter Into New Diagnostic Ultrasound Technology Agreement

Samsung Medison (Seoul, South Korea) and Bracco Imaging (Milan, Italy) have entered into a Memorandum of Understanding (MoU) agreement to pioneer a new area for diagnostic ultrasound devices and contrast agents.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.